We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.27B
AUM Growth
-$156M
Cap. Flow
-$259M
Cap. Flow %
-6.06%
Top 10 Hldgs %
15.28%
Holding
747
New
35
Increased
227
Reduced
378
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 12.82%
3 Communication Services 12.03%
4 Industrials 11.98%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
101
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$12M 0.28%
233,713
-6,708
-3% -$343K
COP icon
102
ConocoPhillips
COP
$144B
$11.9M 0.28%
195,436
-5,980
-3% -$372K
VSH icon
103
Vishay Intertechnology
VSH
$4.6B
$11.6M 0.27%
703,808
-64,664
-8% -$1.14M
TMO icon
104
Thermo Fisher Scientific
TMO
$214B
$11.5M 0.27%
39,176
+12,728
+48% +$3.51M
CCL icon
105
Carnival Corporation Ltd
CCL
$38.1B
$11.5M 0.27%
246,920
-6,900
-3% -$361K
FDX icon
106
FedEx
FDX
$73B
$11.4M 0.27%
69,499
+9,662
+16% +$1.69M
PNC icon
107
PNC Financial Services
PNC
$99.1B
$11.4M 0.27%
82,808
-2,024
-2% -$268K
PTLA
108
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$11.3M 0.26%
415,079
-25,884
-6% -$812K
CNI icon
109
Canadian National Railway
CNI
$78.5B
$11.3M 0.26%
121,754
+2,700
+2% +$248K
ADBE icon
110
Adobe
ADBE
$105B
$11.1M 0.26%
37,675
-2
-0% -$555
GRPN icon
111
Groupon
GRPN
$1.03B
$11M 0.26%
153,421
-12,219
-7% -$862K
XYL icon
112
Xylem
XYL
$28.5B
$10.8M 0.25%
129,106
-11,465
-8% -$914K
CVS icon
113
CVS Health
CVS
$135B
$10.7M 0.25%
196,254
+42,585
+28% +$2.29M
MU icon
114
Micron Technology
MU
$835B
$10.7M 0.25%
276,488
+51,573
+23% +$1.97M
BMY icon
115
Bristol-Myers Squibb
BMY
$129B
$10.6M 0.25%
234,724
-3,541
-1% -$165K
PEP icon
116
PepsiCo
PEP
$196B
$10.6M 0.25%
81,152
-954
-1% -$122K
CAT icon
117
Caterpillar
CAT
$361B
$10.4M 0.24%
76,126
+5,087
+7% +$672K
ICPT
118
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.3M 0.24%
129,815
-12,373
-9% -$1.11M
VCSH icon
119
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$10.3M 0.24%
127,795
+726
+0.6% +$58K
ALDR
120
DELISTED
Alder Biopharmaceuticals
ALDR
$10M 0.23%
850,801
-70,303
-8% -$851K
MGNX icon
121
MacroGenics
MGNX
$233M
$9.78M 0.23%
576,465
-48,683
-8% -$836K
ACN icon
122
Accenture
ACN
$106B
$9.77M 0.23%
52,848
-1,827
-3% -$328K
AMAT icon
123
Applied Materials
AMAT
$347B
$9.76M 0.23%
217,360
+1,715
+0.8% +$72.2K
WM icon
124
Waste Management
WM
$95B
$9.64M 0.23%
83,595
-4,895
-6% -$531K
CVX icon
125
Chevron
CVX
$382B
$9.54M 0.22%
76,694
-1,415
-2% -$171K

Similar funds

Pinnacle Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Pinnacle Associates held 747 positions worth $4.27B, down 3.5% from $4.43B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pinnacle Associates withdrew a net $259M in Q2 2019, closing 43 positions and reducing 378 holdings. Its most notable exit was ARRIS International plc Ordinary Shares, an estimated $29.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Pinnacle Associates opened a new position in Dow Inc worth $5.76M.

  • Pinnacle Associates's largest Q2 2019 buy was Dow Inc: 116,842 shares worth $5.76M.
  • Pinnacle Associates added most to Constellation Brands in Q2 2019, an estimated $7.1M increase.
  • Pinnacle Associates's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $26.5M.
  • Pinnacle Associates fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $29.4M.
  • Pinnacle Associates's ten largest holdings make up 15% of its $4.27B portfolio in Q2 2019.
  • Pinnacle Associates opened 35 new positions and closed 43 in Q2 2019.
  • Pinnacle Associates's portfolio value fell 3.5% quarter-over-quarter to $4.27B.

Based on Pinnacle Associates's 13F filing for Q2 2019, filed 5 Aug 2019.